Cellectar Biosciences Company Profile (NASDAQ:CLRB)

About Cellectar Biosciences

Cellectar Biosciences logoCellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery platform. Its pipeline consists of pre-clinical and clinical product candidates, including radiotherapeutic and chemotherapeutic PDC's. The Company's PDC product portfolio includes CLR 131, which is designed to deliver cytotoxic (cell-killing) radiation directly and selectively to cancer cells and cancer stem cells; CLR 125, which is for the treatment of micro metastatic disease; CLR 124, which is a cancer-targeting positron emission tomography (PET) imaging PDC; CLR 1502, which is for intraoperative tumor margin illumination and non-invasive tumor imaging, and CTX Product Portfolio, including CLR 1601-PTX, CLR 1602-PTX and CLR 1603-PTX product candidates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CLRB
  • CUSIP:
Key Metrics:
  • Previous Close: $2.76
  • 50 Day Moving Average: $2.61
  • 200 Day Moving Average: $2.90
  • 52-Week Range: $1.00 - $22.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.33
  • P/E Growth: 0.00
  • Market Cap: $14.82M
  • Outstanding Shares: 5,368,000
  • Beta: 0.37
Profitability:
  • Return on Equity: -60.53%
  • Return on Assets: -28.74%
Debt:
  • Current Ratio: 5.85%
  • Quick Ratio: 5.85%
Additional Links:
Companies Related to Cellectar Biosciences:

Analyst Ratings

Consensus Ratings for Cellectar Biosciences (NASDAQ:CLRB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cellectar Biosciences (NASDAQ:CLRB)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cellectar Biosciences (NASDAQ:CLRB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/11/2016($0.40)($0.49)ViewN/AView Earnings Details
11/12/2015Q315($0.25)ViewListenView Earnings Details
8/12/2015Q215($0.30)ViewListenView Earnings Details
5/21/2015Q115($0.30)ViewListenView Earnings Details
3/26/2014($0.04)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cellectar Biosciences (NASDAQ:CLRB)
Current Year EPS Consensus Estimate: $-0.80 EPS
Next Year EPS Consensus Estimate: $-0.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.40)($0.40)($0.40)
Q3 20161($0.20)($0.20)($0.20)
Q4 20161($0.20)($0.20)($0.20)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cellectar Biosciences (NASDAQ:CLRB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cellectar Biosciences (NASDAQ:CLRB)
Insider Ownership Percentage: 15.45%
Institutional Ownership Percentage: 1.97%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/20/2016James V CarusoCEOBuy46,948$2.12$99,529.76View SEC Filing  
4/20/2016Paul L BernsDirectorBuy117,371$2.12$248,826.52View SEC Filing  
12/31/2015Awm Investment Company, Inc.Major ShareholderSell100,000$0.69$69,000.00View SEC Filing  
12/29/2015Awm Investment Company, Inc.Major ShareholderSell82,847$0.69$57,164.43View SEC Filing  
12/28/2015Awm Investment Company, Inc.Major ShareholderSell367,966$0.73$268,615.18View SEC Filing  
12/22/2015Awm Investment Company, Inc.Major ShareholderSell7,938$0.90$7,144.20View SEC Filing  
12/21/2015Awm Investment Company, Inc.Major ShareholderSell27,621$0.92$25,411.32View SEC Filing  
12/17/2015Awm Investment Company, Inc.Major ShareholderSell71,225$0.87$61,965.75View SEC Filing  
12/15/2015Awm Investment Company, Inc.Major ShareholderSell44,965$0.82$36,871.30View SEC Filing  
12/4/2015Awm Investment Company, Inc.Major ShareholderSell50,950$1.06$54,007.00View SEC Filing  
11/24/2015Awm Investment Company, Inc.Major ShareholderSell173,802$1.24$215,514.48View SEC Filing  
11/24/2015James V CarusoCEOBuy1,000$1.30$1,300.00View SEC Filing  
11/20/2015Awm Investment Company, Inc.Major ShareholderSell96,806$1.17$113,263.02View SEC Filing  
11/20/2015James V CarusoCEOBuy1,000$1.16$1,160.00View SEC Filing  
11/19/2015James V. CarusoCEOBuy4,000$1.45$5,800.00View SEC Filing  
10/23/2015Awm Investment Company, Inc.Major ShareholderSell8,866$2.00$17,732.00View SEC Filing  
10/6/2015Awm Investment Company, Inc.Major ShareholderSell2,554$2.00$5,108.00View SEC Filing  
10/5/2015Awm Investment Company, Inc.Major ShareholderSell7,500$2.04$15,300.00View SEC Filing  
10/1/2015Awm Investment Company, Inc.Major ShareholderSell27,940$2.05$57,277.00View SEC Filing  
9/29/2015Awm Investment Company, Inc.Major ShareholderSell24,801$2.36$58,530.36View SEC Filing  
8/20/2014John NeisDirectorBuy268,711$3.75$1,007,666.25View SEC Filing  
8/20/2014Simon PedderCEOBuy13,300$3.75$49,875.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cellectar Biosciences (NASDAQ:CLRB)
DateHeadline
News IconPenny Stock Investors are Growing Curious About Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Duncan Research (NASDAQ:CLRB)
www.duncanindependent.com - September 27 at 4:16 PM
News IconKeen Investors Find News on Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Duncan Research (NASDAQ:CLRB)
www.duncanindependent.com - September 24 at 8:30 AM
News IconUnder the Microscope, Zeroing in at Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Duncan Research (NASDAQ:CLRB)
www.duncanindependent.com - September 23 at 9:24 AM
globenewswire.com logoCellectar Biosciences To Present at OktoberINVESTfest - GlobeNewswire (press release) (NASDAQ:CLRB)
globenewswire.com - September 21 at 4:52 PM
publicnow.com logoCellectar Biosciences To Present at OktoberINVESTfest (NASDAQ:CLRB)
www.publicnow.com - September 21 at 4:52 PM
News IconPenny Stock Investors Take an Interest in Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Duncan Research (NASDAQ:CLRB)
www.duncanindependent.com - September 21 at 8:19 AM
globenewswire.com logoCellectar Biosciences to Present at Ladenburg Thalmann 2016 Healthcare Conference - GlobeNewswire (press release) (NASDAQ:CLRB)
globenewswire.com - September 21 at 8:19 AM
4-traders.com logoCellectar Biosciences : to Present at Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:CLRB)
www.4-traders.com - September 20 at 10:05 AM
finance.yahoo.com logoCellectar Biosciences to Present at Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:CLRB)
finance.yahoo.com - September 19 at 9:00 AM
News IconCellectar Biosciences Incorporated (NASDAQ:CLRB) Short Interest Decreased By 3.6% - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - September 17 at 8:59 AM
News IconStock Turning Lower in Trade: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - September 14 at 4:21 PM
globenewswire.com logoCellectar Biosciences Announces Lead Compound CLR 131 To Be Studied In Head and Neck Cancer in $12M ... - GlobeNewswire (press release) (NASDAQ:CLRB)
globenewswire.com - September 14 at 8:31 AM
News IconStock Gapping Higher Pre-Market: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - September 13 at 9:03 AM
News IconTime To Put On The Watch List? - Cellectar Biosciences, Inc. (NASDAQ:CLRB), Lpath Inc. (NASDAQ:LPTN) - The Voice Registrar (NASDAQ:CLRB)
voiceregistrar.com - September 13 at 9:03 AM
News IconCellectar Biosciences Inc (NASDAQ:CLRB): Why We're Not Willing To Pull The Trigger Just Yet - Street Register (NASDAQ:CLRB)
streetregister.com - September 13 at 9:03 AM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:CLRB)
biz.yahoo.com - September 13 at 9:03 AM
finance.yahoo.com logoCellectar Biosciences Announces Lead Compound CLR 131 To Be Studied In Head and Neck Cancer in $12M University of Wisconsin SPORE Grant (NASDAQ:CLRB)
finance.yahoo.com - September 12 at 9:04 AM
finance.yahoo.com logo8:34 am Cellectar Biosciences announces CLR 131 will be evaluated by the University of Wisconsin in combination with external beam radiation as a potential combination treatment for head & neck cancers (NASDAQ:CLRB)
finance.yahoo.com - September 12 at 9:04 AM
rttnews.com logoCellectar Biosciences Inc. (CLRB) Has Risen To Nearly A 2-Month High (NASDAQ:CLRB)
www.rttnews.com - September 10 at 8:56 AM
News IconHC Stocks in Top Row= Cellectar Biosciences Inc (CLRB), Exelixis, Inc. (NASDAQ:EXEL) - share market updates (press release) (NASDAQ:CLRB)
sharemarketupdates.com - September 9 at 4:09 PM
News IconBiotech Stocks Worth a Closer Look: GTx, Inc. (NASDAQ:GTXI), Cellectar Biosciences, Inc. (NASDAQ:CLRB) - The Voice Registrar (NASDAQ:CLRB)
voiceregistrar.com - September 9 at 4:09 PM
News IconHealthcare Stocks To Watch: Cellectar Biosciences, Inc. (NASDAQ:CLRB), BioTime, Inc. (NYSEMKT:BTX) - National Daily Press (NASDAQ:CLRB)
www.nationaldailypress.com - September 9 at 9:05 AM
News IconShares Higher in Today's Session: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - September 8 at 4:09 PM
finance.yahoo.com logoCellectar Biosciences To Present at the 18th Annual Rodman & Renshaw Global Investment Conference (NASDAQ:CLRB)
finance.yahoo.com - September 6 at 9:09 AM
News IconShares Gapping Higher Pre-Market: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - September 3 at 8:55 AM
News IconHC Stocks in Top Row- Cellectar Biosciences Inc (NASDAQ:CLRB), Exelixis, Inc. (NASDAQ:EXEL) - share market updates (press release) (NASDAQ:CLRB)
sharemarketupdates.com - September 3 at 8:55 AM
News IconStock Down in Trading Session: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - September 1 at 11:48 AM
News IconCrowd Sentiment & Wall Street Views on Cellectar Biosciences, Inc. (NASDAQ:CLRB)? - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - August 23 at 8:26 AM
finance.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Financials (NASDAQ:CLRB)
finance.yahoo.com - August 18 at 4:19 PM
finance.yahoo.com logoSeeThruEquity Issues Update on Cellectar Biosciences, Inc. (Nasdaq: CLRB) (NASDAQ:CLRB)
finance.yahoo.com - August 18 at 11:05 AM
News IconCellectar Biosciences Inc (NASDAQ:CLRB) Might Be Due A Bounce - Street Register (NASDAQ:CLRB)
streetregister.com - August 17 at 4:25 PM
News IconCellectar Biosciences Inc (NASDAQ:CLRB) Might Be Due A Bounce (NASDAQ:CLRB)
streetregister.com - August 17 at 11:17 AM
finance.yahoo.com logoEdited Transcript of CLRB earnings conference call or presentation 15-Aug-16 12:30pm GMT (NASDAQ:CLRB)
finance.yahoo.com - August 17 at 11:17 AM
News IconShares Trading Down in Session: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - August 16 at 9:31 PM
News IconCellectar Biosciences announces recent key accomplishments (NASDAQ:CLRB)
medicalphysicsweb.org - August 16 at 4:18 PM
publicnow.com logoCellectar Biosciences Announces Recent Key Accomplishments and Second Quarter 2016 Financial Results (NASDAQ:CLRB)
www.publicnow.com - August 11 at 10:05 PM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CLRB)
biz.yahoo.com - August 11 at 4:24 PM
publicnow.com logoCellectar Biosciences to Host Conference Call on August 15 to Report Second Quarter 2016 Financial Results and Corporate Performance (NASDAQ:CLRB)
www.publicnow.com - August 8 at 9:06 AM
streetinsider.com logoCellectar Biosciences (CLRB) Receives Multimillion Second Phase of NCI SBIR Contract for CLR 131 Phase 2 (NASDAQ:CLRB)
www.streetinsider.com - August 3 at 4:22 PM
streetinsider.com logoCellectar Biosciences (CLRB) Receives Multimillion Second Phase of NCI SBIR Contract for CLR 131 Phase 2 - StreetInsider.com (NASDAQ:CLRB)
www.streetinsider.com - August 3 at 11:35 AM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant (NASDAQ:CLRB)
biz.yahoo.com - July 27 at 4:04 PM
News IconCellectar Biosciences, Inc. (NASDAQ:CLRB): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 22 at 11:46 AM
4-traders.com logoStockNewsNow.com : Publishes New SNNLive Video Interview with Cellectar Biosciences, Inc. Discussing Corporate Updates and Clinical Development (NASDAQ:CLRB)
www.4-traders.com - July 21 at 9:48 PM
finance.yahoo.com logoStockNewsNow.com Publishes New SNNLive Video Interview with Cellectar Biosciences, Inc. Discussing Corporate Updates and Clinical Development (NASDAQ:CLRB)
finance.yahoo.com - July 21 at 8:30 AM
News IconIncreased Stock Volatility Watch: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 20 at 5:24 PM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, (NASDAQ:CLRB)
biz.yahoo.com - July 20 at 4:03 PM
News IconCellectar Biosciences Incorporated (NASDAQ:CLRB) Sellers Covered 3.93% of Their Shorts - Consumer Eagle (NASDAQ:CLRB)
www.consumereagle.com - July 20 at 11:46 AM
News IconEquity Roundup: Stock Performance Focus on Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Press Telegraph (NASDAQ:CLRB)
presstelegraph.com - July 20 at 11:46 AM
finance.yahoo.com logoCellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations (NASDAQ:CLRB)
finance.yahoo.com - July 20 at 8:30 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Cellectar Biosciences, Inc. (NASDAQ:CLRB) - TGP (NASDAQ:CLRB)
telanaganapress.com - July 19 at 4:22 PM

Social

Cellectar Biosciences (NASDAQ:CLRB) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff